Abstract
The authors recently performed what to their knowledge is the largest survey published to date regarding clinical trials of biotherapies for solid tumors to review their content and quality. They found evidence of publication bias and suggest improvements of strategies and methodologic tools when evaluating negative study results.
Original language | English |
---|---|
Pages (from-to) | 653 |
Number of pages | 1 |
Journal | Cancer |
Volume | 103 |
Issue number | 4 |
DOIs | |
Publication status | Published - Feb 15 2005 |
ASJC Scopus subject areas
- Cancer Research
- Oncology